Anastasia M. Shields

FDA investigator · also recorded as La Anastasia Shields

Appears on 45 documents from 2016 to 2026, most often at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

45
Documents on file
4.7
Observations per 483
2016
First seen
2026
Most recent

What they cite most

From 212 observations

Activity by year

2016: 2, 2017: 2, 2018: 4, 2019: 3, 2021: 2, 2022: 5, 2023: 9, 2024: 9, 2025: 7, 2026: 2

Where

India 21 · Pennsylvania 8 · Japan 3 · Australia 2 · West Virginia 2 · Illinois 1

Is Anastasia M. Shields coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

45 documents, newest first
FirmOpen
483 Cipla LimitedApr 17, 2026 · Salcette, India
483 Apotek Production & Laboratorier ABJan 29, 2026 · Umea, Sweden
483 Sato Pharmaceutical Co., LtdNov 21, 2025 · Hachioji, Japan
483 Quotient Sciences - Philadelphia, LLCSep 17, 2025 · Boothwyn, Pennsylvania
483 PETNET Solutions, Inc.Sep 2, 2025 · North Wales, Pennsylvania
Amended 483 Sumitomo Dainippon Pharma Co., Ltd.Jul 11, 2025 · Oita, Japan
483 Shionogi Pharma Co., Ltd.Jul 1, 2025 · Kanegasaki, Japan

About this profile

What does Anastasia M. Shields inspect?

Anastasia M. Shields appears on 45 documents on file covering 41 sites, most often in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.100 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Anastasia M. Shields is dated Apr 17, 2026.

FDA Investigator Anastasia M. Shields: 483s & Inspections · FDA Intel